Dynamic hyperinflation, arterial blood oxygen, and airway oxidative stress in stable patients with COPD

Chest

Volumn 140, Issue 4, 2011, Pages 961-969

  García Rio, Francisco ^a   Romero, David ^a   Lores, Vanesa ^b   Casitas, Raquel ^a   Hernanz, Angel ^a   Galera, Raul ^a   Alvarez Sala, Rodolfo ^a   Torres, Isabel ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE;

ADULT; AGED; AIRWAY; AIRWAY OXIDATIVE STRESS; ARTERIAL OXYGEN TENSION; ARTICLE; BODY MASS; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENSITOMETRY; DISEASE SEVERITY; DYNAMIC HYPERINFLATION; DYSPNEA; ENZYME IMMUNOASSAY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG PARENCHYMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT PARAMETERS; SMOKING; WALKING;

EID: 80053543411     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2788     Document Type: Article

References (33)

1. Rahman I, MacNee W. Role of oxidants/antioxidants in smoking-induced lung diseases. Free Radic Biol Med. 1996; 21(5):669-681. (Pubitemid 26331096)
2. Boots AW, Haenen GR, Bast A. Oxidant metabolism in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46(suppl 22):14s-27s. (Pubitemid 37351733)
3. Rahman I, Gilmour PS, Jimenez LA, MacNee W. Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem. 2002;234-235(1-2):239-248. (Pubitemid 34777863)
4. Montuschi P. Exhaled breath condensate analysis in patients with COPD. Clin Chim Acta. 2005;356(1-2):22-34. (Pubitemid 40779884)
5. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41(12 Pt 2): 1819-1828.
6. Montuschi P, Ragazzoni E, Valente S, et al. Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate. Infl amm Res. 2003;52(12):502-507. (Pubitemid 38058224)
7. Montuschi P, Collins JV, Ciabattoni G, et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1175-1177.
8. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest. 2003;124(4):1373-1380. (Pubitemid 37290047)
9. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax. 2003;58(4):294-298. (Pubitemid 36411413)
10. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004;18(15): 1791-1800. (Pubitemid 39602265)
11. Rabe KF, Hurd S, Anzueto A, et alGlobal Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
12. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012. (Pubitemid 38269277)
13. Torres I, Allona M, Martínez M, Lores V, Rojo B, García-Río F . Severity-related differences in lung attenuation in men with COPD. Arch Bronconeumol. 2010;46(2):56-63.
14. Miller MR, Hankinson J, Brusasco V, et alATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26(2): 319-338. (Pubitemid 41079078)
15. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3): 511-522. (Pubitemid 41264217)
16. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720-735. (Pubitemid 41448672)
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests. European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J. 1993;(suppl 16):5s-40s.
18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-117.
19. American Thoracic Society. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211-277.
20. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinfl ation. Am J Respir Crit Care Med. 2009;180(6):506-512.
21. Jones NL, Makrides L, Hitchcock C, Chypchar T, McCartney N. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis. 1985;131(5):700-708. (Pubitemid 15066853)
22. Habib MP, Tank LJ, Lane LC, Garewal HS. Effect of vitamin E on exhaled ethane in cigarette smokers. Chest. 1999; 115(3):684-690. (Pubitemid 29129945)
23. Kasielski M, Nowak D. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease. Respir Med. 2001;95(6):448-456. (Pubitemid 32621997)
24. Jafari B, Ouyang B, Li LF, Hales CA, Quinn DA. Intracellular glutathione in stretch-induced cytokine release from alveolar type-2 like cells. Respirology. 2004;9(1):43-53. (Pubitemid 38647769)
25. Makris D, Paraskakis E, Korakas P, et al. Exhaled breath condensate 8-isoprostane, clinical parameters, radiological indices and airway infl ammation in COPD. Respiration. 2008; 75(2):138-144. (Pubitemid 351363866)
26. Papaioannou AI, Mazioti A, Kiropoulos T, et al. Systemic and airway inflammation and the presence of emphysema in patients with COPD. Respir Med. 2010;104(2):275-282.
27. Tuder RM, Zhen L, Cho CY, et al. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol. 2003;29(1):88-97. (Pubitemid 36783320)
28. Pialoux V, Mounier R, Brown AD, Steinback CD, Rawling JM, Poulin MJ. Relationship between oxidative stress and HIF-1 α mRNA during sustained hypoxia in humans. Free Radic Biol Med. 2009;46(2):321-326.
29. Guzy RD, Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol. 2006;91(5):807-819. (Pubitemid 44266577)
30. Vassilakopoulos T, Roussos C, Zakynthinos S. The immune response to resistive breathing. Eur Respir J. 2004;24(6) : 1033-1043. (Pubitemid 39642297)
31. Chapman KE, Sinclair SE, Zhuang D, Hassid A, Desai LP, Waters CM. Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005;289(5):L834-L841. (Pubitemid 41504415)
32. Banerjee AK, Mandal A, Chanda D, Chakraborti S. Oxidant, antioxidant and physical exercise. Mol Cell Biochem. 2003; 253(1-2):307-312. (Pubitemid 37321737)
33. Mercken EM, Gosker HR, Rutten EP, et al. Systemic and pulmonary oxidative stress after single-leg exercise in COPD. Chest. 2009;136(5):1291-1300.